Literature DB >> 1932290

Effects of factor VIII concentrates on the immune system in hemophilic patients.

S Schulman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1932290     DOI: 10.1007/bf01703246

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  41 in total

1.  Modulation of human monocyte functions by factor VIII-anti-factor VIII complexes present in an affinity-purified factor VIII product.

Authors:  J W Mannhalter; R Ahmad; M M Eibl; H Leibl
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

2.  Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus.

Authors:  R Madhok; A Gracie; G D Lowe; A Burnett; K Froebel; E Follett; C D Forbes
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-18

3.  Antihemophilic factor [factor VIII] preparations inhibit lymphocyte proliferation and production of interleukin-2.

Authors:  M M Lederman; C Saunders; Z Toossi; N Lemon; B Everson; O D Ratnoff
Journal:  J Lab Clin Med       Date:  1986-05

4.  Pulmonary hypertension in hemophilia.

Authors:  S Schulman; H Johnsson; S Blomqvist
Journal:  Ann Intern Med       Date:  1988-11-01       Impact factor: 25.391

Review 5.  Activation of human immunodeficiency virus.

Authors:  G J Nabel
Journal:  J Lab Clin Med       Date:  1988-05

6.  Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection.

Authors:  T C Quinn; P Piot; J B McCormick; F M Feinsod; H Taelman; B Kapita; W Stevens; A S Fauci
Journal:  JAMA       Date:  1987-05-15       Impact factor: 56.272

7.  Inhibition of interleukin-2 secretion by factor VIII concentrates: a possible cause of immunosuppression in haemophiliacs.

Authors:  R Thorpe; P Dilger; N J Dawson; T W Barrowcliffe
Journal:  Br J Haematol       Date:  1989-03       Impact factor: 6.998

8.  Factor VIII:C concentrate purified from plasma using monoclonal antibodies: human studies.

Authors:  D B Brettler; A D Forsberg; P H Levine; J Petillo; K Lamon; J L Sullivan
Journal:  Blood       Date:  1989-05-15       Impact factor: 22.113

9.  Interferon production in severe hemophiliacs with and without HIV antibodies.

Authors:  A Ruffault; N Genetet; A M Berthier; M Pommereuil; C Duvail; P Andre; H Morel; B Genetet; B Fauconnier
Journal:  J Interferon Res       Date:  1988-02

10.  A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses.

Authors:  S F Stein; B L Evatt; J S McDougal; D N Lawrence; R C Holman; R B Ramsey; T J Spira
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

View more
  4 in total

1.  Markers of Blood Cell Activation and Complement Activation in Factor VIII and von Willebrand Factor Concentrates.

Authors:  Martin F Brodde; Beate E Kehrel
Journal:  Transfus Med Hemother       Date:  2010-07-14       Impact factor: 3.747

2.  Comparison of immunodeficiency and AIDS defining conditions in HIV negative and HIV positive men with haemophilia A.

Authors:  C A Sabin; K J Pasi; A N Phillips; P Lilley; M Bofill; C A Lee
Journal:  BMJ       Date:  1996-01-27

Review 3.  Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV.

Authors:  P H Duesberg
Journal:  Genetica       Date:  1995       Impact factor: 1.082

Review 4.  Five myths about AIDS that have misdirected research and treatment.

Authors:  R S Root-Bernstein
Journal:  Genetica       Date:  1995       Impact factor: 1.082

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.